Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 8/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29597386 | 0.89 | TK1 (0.39) | TK1ALDH1A1NPSR1 | |
| SCHEMBL14388593 | 0.89 | TK1 (0.43) | TK1ALDH1A1ALBPKMLMNA | |
| SCHEMBL27436150 | 0.89 | TK1 (0.43) | TK1ALDH1A1ALBPKMLMNA | |
| SCHEMBL887851 | 0.88 | TK1 (0.43) | TK1ALDH1A1ALBPKMLMNA | |
| SCHEMBL1517629 | 0.88 | TK1 (0.44) | TK1ALDH1A1ALBPKMLMNA | |
| SCHEMBL28249854 | 0.87 | TK1 (0.42) | TK1ALDH1A1ALBPKMLMNA | |
| SCHEMBL6923545 | 0.86 | RNASE1 (0.41) | TK1 | |
| SCHEMBL6923541 | 0.86 | RNASE1 (0.41) | TK1 | |
| SCHEMBL27602624 | 0.85 | TK1 (0.43) | TK1ALBPKMLMNABLM | |
| SCHEMBL8299476 | 0.85 | TYMP (0.44) | TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1122040-C | Suger modified nucleosides and their use for synthesis of oligonucleotides | ICN PHARMACEUTICALS (US) | 2003-09-24 | — | — | CN | disclosed |
| EP-0789706-A4 | SUGAR MODIFIED NUCLEOSIDES AND THEIR USE FOR SYNTHESIS OF OLIGONUCLEOTIDES | ICN PHARMACEUTICALS (US) | 1999-08-11 | — | — | EP | disclosed |
| CN-1170412-A | Suger modified nucleosides and their use for synthesis of oligonucleotides | ICN PHARMACEUTICALS (US) | 1998-01-14 | — | — | CN | disclosed |
| EP-0789706-A1 | SUGAR MODIFIED NUCLEOSIDES AND THEIR USE FOR SYNTHESIS OF OLIGONUCLEOTIDES | ICN PHARMACEUTICALS (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1996014329-A1 | SUGAR MODIFIED NUCLEOSIDES AND THEIR USE FOR SYNTHESIS OF OLIGONUCLEOTIDES | ICN PHARMACEUTICALS (US) | 1996-05-17 | — | — | WO | disclosed |